Standardization of Body Composition Status in Patients with Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the Assessment of Sarcopenia and Patient Outcome Correlation

Antonella Borrelli(Sapienza University of Rome), Valeria Panebianco(Sapienza University of Rome), Ailin Dehghanpour(Policlinico Umberto I), Michela Roberto(Policlinico Umberto I), Martina Pecoraro(Sapienza University of Rome), Emanuele Messina(Policlinico Umberto I), Nicholas Landini(Sapienza University of Rome), Carlo Catalano(Unknown), Daniele Santini(Policlinico Umberto I), Francesco Del Giudice(Sapienza University of Rome), Stefano Perotti(Sapienza University of Rome), Maurizio Muscaritoli(Sapienza University of Rome), Leonardo Cristofani(Sapienza University of Rome)
Cancers
May 29, 2023
10.3390/cancers15112968
Cited by 12

Related Papers

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
|JAMA Oncology|2018|418
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
|The Lancet Oncology|2020|322
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
|Journal of Clinical Oncology|2015|181